Financials
- Market Capitalization 423.45 M
- Employee 350
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2909 | AQST Aquestive Therapeutics, Inc. - Common Stock | 4.09 USD | +0.74% | -5.98% | -2.85% | +1.24% | 513.09 M USD | ||
| 2912 | TLRY Tilray Brands, Inc. - Common Stock | 4.38 USD | -1.79% | +1.15% | -13.78% | +553.73% | 510.48 M USD | ||
| 3057 | KMDA Kamada Ltd. - Ordinary Shares | 7.26 USD | +1.26% | -0.82% | -2.94% | -7.52% | 418.80 M USD | ||
| 3078 | CGC Canopy Growth Corporation - Common Shares | 0.96 USD | 0.00% | -1.03% | -3.03% | -18.64% | 405.27 M USD |
Frequently asked questions about Evolus, Inc. - Common Stock
What is the Evolus, Inc. - Common Stock stock price today?
The current price of Evolus, Inc. - Common Stock (EOLS) is 6.43. Over the past 24 hours, the stock has changed by -1.38%. Follow the EOLS chart for real-time price dynamics.
What is the stock ticker of Evolus, Inc. - Common Stock?
Evolus, Inc. - Common Stock trades under the ticker EOLS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Evolus, Inc. - Common Stock stock going up?
EOLS has changed by -6.68% over the last week, -4.88% over the last month, and -33.02% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Evolus, Inc. - Common Stock net income for the last quarter?
Evolus, Inc. - Common Stock reported net income of -10.67 M for the last quarter. The previous quarter showed 130 K, which means net income changed by -8310.77%.
How many employees does Evolus, Inc. - Common Stock have?
As of the latest available data, Evolus, Inc. - Common Stock has 350 employees. Workforce size can provide additional context about the company's scale and operations.
What is Evolus, Inc. - Common Stock EBITDA?
Evolus, Inc. - Common Stock EBITDA is 19.74 M, and its EBITDA margin is 26.99%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Evolus, Inc. - Common Stock stock?
You can buy Evolus, Inc. - Common Stock (EOLS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Evolus, Inc. - Common Stock stock?
Investing in Evolus, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EOLS chart and related analysis on metatrader.com as part of your research.